Jiang Jun Jason

Jiang Jun Jason, serving as CFO and COO, has maintained a consistently one-sided disposition in his SEC Form 4 filings, with all 69 reported transactions reflecting sales and no open-market purchases. The aggregate sell value across his reported activity totals $87,904.32, a figure that includes 25 recent sales concentrated entirely in NAMI between May 29 and June 30, 2026. The transaction sizes vary widely, from nominal amounts such as $0.39 on June 24 and $7.32 on June 29 to more substantial disposals like $11,520 on June 8 and $6,900 on June 10, indicating a pattern of frequent, small-to-mid-sized sales rather than a single large liquidation event. The recent trading cadence shows near-daily activity in late June, with sales recorded on June 1, 2, 3, 4, 5, 8, 9, 10, 11, 17, 18, 22, 24, 26, 29, and 30. The largest individual transactions occurred in the first half of June, including the $11,520 sale on June 8 and a $6,100 sale on June 3, while the late-June trades trend smaller, with several under $1,000. Notably, there are no reported acquisitions, option exercises, or compensatory grants in the recent window—every transaction is coded as an open-market sale (S), which represents a deliberate reduction of his position in the company. The absence of any purchase activity, combined with the steady stream of sales across the reporting period, points to a clear net-selling bias. While the dollar values are modest in absolute terms—the largest single transaction barely exceeds $11,000—the frequency and consistency of the sales suggest an ongoing program of share disposals rather than a one-off event. All recent activity is confined to a single ticker, NAMI, with no diversification across other securities in the filings reviewed.